TIGIT and myeloid sarcoma: TIGIT expression on the surface membrane was negligible on human B cells, and there were no significant differences in the absolute numbers of ex vivo TIGIT+ B cells between healthy controls and patients with MS (Supplemental Figure 3, A and B).